BioSpace News Archive

A conference call will be held at 5:00 p.m. Eastern Time to discuss those results.

An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

The company announced its financial results for the six-months ended June 30, 2017, as approved by the Company’s Board of Directors on October 27, 2017.

Management will provide a business update and discuss the financial results for the third quarter of 2017 on the same day.

Four out of six evaluable HRAS mutant HNSCC patients enrolled in the study achieved a confirmed partial response.

Microbix Biosystems Inc. announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017.

MR Solutions is expanding its management team following world-wide sales success of their ground-breaking, cryogen free preclinical MRI scanners.

The Rare Genomics (RG) Institute is delighted to announce the launch of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge, a global competition that offers rare disease researchers, who traditionally have difficulty attracting funding, grants of cash and the latest life science innovations and technologies.

Eagle submitted, and the FDA accepted for filing, its NDA under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act for PEMFEXY ready-to-dilute in December 2016.

Relevium Technologies is pleased to announce it has appointed Abis Hussain as the company’s Senior Marketing Officer, overseeing the company’s overall marketing and branding activities for its current and future portfolio of e-brands.